Skip to main content
Figure 4 | Breast Cancer Research

Figure 4

From: The progestational and androgenic properties of medroxyprogesterone acetate: gene regulatory overlap with dihydrotestosterone in breast cancer cells

Figure 4

Glucocorticoid and androgenic activity of the synthetic progestins and Dexamethasone. HeLa cells (GR+, PR-, AR-) were transfected with or without an AR expression vector, PRE2/luciferase construct and Renilla control, and treated for 20 hours with 10 nmol/l MPA, R5020, DHT, or dexamethasone. Relative luciferase activity was measured. Stippled bars are GR+ cells lacking AR; grey bars are GR+ and AR+ cells. AR, androgen receptor; DEX, dexamethasone; DHT, dihydrotestosterone; GR, glucocorticoid receptor; MPA, medroxyprogesterone acetate; PR, progesterone receptor; RLU, relative luciferase units.

Back to article page